- Di processo
- Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in females worldwide. Progresses achieved in pharmacologic therapies and treatment personalization is progressively raising breast cancer cure rates and prolonging survival in patients with advanced disease. Taking basic science advancements into everyday clinical practice remains a major issue, and it is achieved through translational research, which comes with incredible opportunities but also increasing challenges at an academic level. In the current scenario of innovative therapeutic approaches, novel diagnostic and molecular tools, and the evolution of personalized oncology algorithms, contamination between scientific and clinical disciplines is key to fuel the translational process.